Yamashita Kotaro, Makino Tomoki, Miyata Hiroshi, Miyazaki Yasuhiro, Takahashi Tsuyoshi, Kurokawa Yukinori, Yamasaki Makoto, Nakajima Kiyokazu, Takiguchi Shuji, Mori Masaki, Doki Yuichiro
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan.
Ann Surg Oncol. 2016 Jun;23(6):2106-14. doi: 10.1245/s10434-015-5045-7. Epub 2016 Jan 11.
For some types of cancer, postoperative complications can negatively influence survival, but the association between these complications and oncological outcomes is unclear for patients with esophageal cancer who receive preoperative treatments.
Data were retrospectively analyzed for patients who underwent curative resection following preoperative chemotherapy for esophageal squamous cell carcinoma from 2001 to 2011. Clinicopathological parameters and cancer-specific survival (CSS) were compared between patients with and without severe postoperative complications, grade III or higher, using the Clavien-Dindo classification.
Of 255 patients identified, 104 (40.8 %) postoperatively developed severe complications. The most common complication was atelectasis in 61 (23.9 %), followed by pulmonary infection in 22 (8.6 %). Three-field lymphadenectomy, longer operation time, and more blood loss were significantly associated with a higher incidence of severe complications. Multivariate analysis of CSS revealed severe complications [hazard ratio (HR) = 1.642, 95 % confidence interval (95 % CI) 1.095-2.460, p = 0.016] as a significant prognostic factor along with pT stage [HR = 2.081, 95 % CI 1.351-3.266, p < 0.001] and pN stage [HR = 3.724, 95 % CI 2.111-7.126, p < 0.001], whereas postoperative serum C-reactive protein value was not statistically significant. Among all complications, severe pulmonary infection was the only independent prognostic factor [HR = 2.504, 95 % CI 1.308-4.427, p = 0.007].
The incidence of postoperative infectious complications, in particular pulmonary infection, is associated with unfavorable prognosis in patients with esophageal cancer undergoing preoperative chemotherapy.
对于某些类型的癌症,术后并发症会对生存率产生负面影响,但对于接受术前治疗的食管癌患者,这些并发症与肿瘤学结局之间的关联尚不清楚。
对2001年至2011年期间接受术前化疗后行根治性切除术的食管鳞状细胞癌患者的数据进行回顾性分析。采用Clavien-Dindo分类法,比较有和没有严重术后并发症(III级或更高)的患者的临床病理参数和癌症特异性生存(CSS)情况。
在255例患者中,104例(40.8%)术后出现严重并发症。最常见的并发症是肺不张,共61例(23.9%),其次是肺部感染22例(8.6%)。三野淋巴结清扫术、手术时间较长和失血较多与严重并发症的发生率较高显著相关。CSS的多因素分析显示,严重并发症[风险比(HR)=1.642,95%置信区间(95%CI)1.095 - 2.460,p = 0.016]是一个重要的预后因素,同时pT分期[HR = 2.081,95%CI 1.351 - 3.266,p < 0.001]和pN分期[HR = 3.724,95%CI 2.111 - 7.126,p < 0.001]也是,而术后血清C反应蛋白值无统计学意义。在所有并发症中,严重肺部感染是唯一的独立预后因素[HR = 2.504,95%CI 1.308 - 4.427,p = 0.007]。
术后感染性并发症,尤其是肺部感染的发生率,与接受术前化疗的食管癌患者的不良预后相关。